TMI-1

TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.

287403-39-8

≥ 2 years

>98% (HPLC)

398.5

C17H22N2O5S2

Research use only, not for human use.

Apoptosis | MMP

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

48420171 3x 5 nmol

Ask

AMM19836V 100 µL

Ask

AN301536L-01 50 µL

Ask

AN301536L-02 100 µL

Ask

G1162 96 Tests

Ask

MBS014332-01 48 Well

Ask